Piramal Pharma

{
  "main_header": {
    "sid": 1003728,
    "name": "Piramal Pharma",
    "stock_name": "Piramal Pharma",
    "full_name": "Piramal Pharma Ltd",
    "name_url": "stocks-analysis/piramal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "197.75",
    "chg": -8.55,
    "chgp": "-4.14%",
    "dir": -1,
    "prev_price": "206.30",
    "mcapval": "26,940.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543635,
    "symbol": "PPLPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE0DK501011",
    "curr_date": "Oct 01, 03:30 PM",
    "curr_time": "05:53 AM",
    "last_traded_at": "Oct 01, 03:30 PM IST",
    "bse_nse_vol": "37.68 lacs",
    "exc_status": "Active",
    "traded_date": "Oct 01, 2026",
    "traded_date_str": "2026 10 01",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/piramal-pharma-1003728-0&utm_source=Website_LockedLinks_StockPageName",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Piramal Pharma Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-4212096",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PiramalPharmaLt_mojoScore_4212096.png",
        "date": "2026-10-02 10:10:17",
        "description": "Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 October 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4210509",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/PiramalPharmaLt_technicaldot_4210509.png",
        "date": "2026-10-01 08:04:19",
        "description": "Piramal Pharma Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a recent downgrade in its Mojo Grade to Sell, the stock’s price action and technical parameters reveal a complex interplay of bullish and bearish signals, warranting a closer examination for investors navigating the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4207696",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4207696.png",
        "date": "2026-09-29 08:07:30",
        "description": "Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a recent day decline of 1.78% to close at ₹206.45, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This analysis delves into the latest technical parameters, including MACD, RSI, moving averages, and other momentum indicators, to provide a comprehensive view of the stock’s current market positioning."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4201796",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4201796.png",
        "date": "2026-09-23 08:05:00",
        "description": "Piramal Pharma Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late September 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical indicators, reflecting both resilience and caution within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4200465",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4200465.png",
        "date": "2026-09-22 08:07:51",
        "description": "Piramal Pharma Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, supported by key indicators such as MACD, Bollinger Bands, and moving averages. Despite some mixed signals on monthly charts, the stock’s recent price action and technical parameters suggest an improving outlook for this small-cap pharmaceutical player."
      },
      {
        "title": "Piramal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-by-marketsmojo-4199770",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_mojoScore_4199770.png",
        "date": "2026-09-21 10:10:31",
        "description": "Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4194311",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_technicaldot_4194311.png",
        "date": "2026-09-16 08:09:42",
        "description": "Piramal Pharma Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of mid-2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving technical landscape, key momentum indicators, and comparative performance against the broader Sensex benchmark."
      },
      {
        "title": "Piramal Pharma Ltd Falls 1.38%: 4 Key Factors Driving the Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/piramal-pharma-ltd-falls-138-4-key-factors-driving-the-weekly-move-4191195",
        "imagepath": "",
        "date": "2026-09-12 11:01:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>7 Sep:</strong> New 52-week high at Rs.221.85</p>\n                    <p><strong>8 Sep:</strong> All-time high reached at Rs.226.9 with exceptional volume surge</p>\n                    <p><strong>9 Sep:</strong> Sharp price correction amid market weakness</p>\n                    <p><strong>11 Sep:</strong> Week closes at Rs.211.25, down 1.38%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.219.65</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.211.25</div><div class=\"stat-change ne..."
      },
      {
        "title": "Piramal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/piramal-pharma-ltd-is-rated-sell-by-marketsmojo-4189305",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/PiramalPharmaLt_mojoScore_4189305.png",
        "date": "2026-09-10 10:10:03",
        "description": "Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 504,
    "sid": "1003728",
    "stock_news_url": "https://www.marketsmojo.com/news/piramal-pharma-1003728"
  },
  "announcements": [
    {
      "caption": "Clarification On News Item Which Appeared In The",
      "datetime": "01-Oct-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Expiry And Non-Renewal Of Commercial Arrangement With Bayer Pharmaceuticals Private Limited",
      "datetime": "01-Oct-2026",
      "details": "Please refer attachment.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "30-Sep-2026",
      "details": "Disclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 -Appointment of Senior Management Personnel.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has declared <strong>1%</strong> dividend, ex-date: 16 Jul 25",
          "dt": "2025-07-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Piramal Pharma Ltd has announced <strong>5:46</strong> rights issue, ex-date: 02 Aug 23",
          "dt": "2023-08-02",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Piramal Pharma Ltd is Rated Sell

2026-10-02 10:10:17

Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 October 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-10-01 08:04:19

Piramal Pharma Ltd has experienced a nuanced shift in its technical momentum, with key indicators signalling a transition from bullish to mildly bullish territory. Despite a recent downgrade in its Mojo Grade to Sell, the stock’s price action and technical parameters reveal a complex interplay of bullish and bearish signals, warranting a closer examination for investors navigating the Pharmaceuticals & Biotechnology sector.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-29 08:07:30

Piramal Pharma Ltd has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more confident bullish trend. Despite a recent day decline of 1.78% to close at ₹206.45, the stock’s technical indicators present a complex picture, with some signals pointing to strength while others suggest caution. This analysis delves into the latest technical parameters, including MACD, RSI, moving averages, and other momentum indicators, to provide a comprehensive view of the stock’s current market positioning.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-23 08:05:00

Piramal Pharma Ltd has experienced a nuanced shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of late September 2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock exhibits a complex interplay of technical indicators, reflecting both resilience and caution within the Pharmaceuticals & Biotechnology sector.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-22 08:07:51

Piramal Pharma Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bullish to a bullish trend, supported by key indicators such as MACD, Bollinger Bands, and moving averages. Despite some mixed signals on monthly charts, the stock’s recent price action and technical parameters suggest an improving outlook for this small-cap pharmaceutical player.

Read full news article

Piramal Pharma Ltd is Rated Sell by MarketsMOJO

2026-09-21 10:10:31

Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 21 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Piramal Pharma Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-09-16 08:09:42

Piramal Pharma Ltd has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend as of mid-2026. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. This analysis delves into the evolving technical landscape, key momentum indicators, and comparative performance against the broader Sensex benchmark.

Read full news article

Piramal Pharma Ltd Falls 1.38%: 4 Key Factors Driving the Weekly Move

2026-09-12 11:01:26

Key Events This Week

7 Sep: New 52-week high at Rs.221.85

8 Sep: All-time high reached at Rs.226.9 with exceptional volume surge

9 Sep: Sharp price correction amid market weakness

11 Sep: Week closes at Rs.211.25, down 1.38%

Week Open

Rs.219.65

Week Close

Rs.211.25

Read full news article

Piramal Pharma Ltd is Rated Sell by MarketsMOJO

2026-09-10 10:10:03

Piramal Pharma Ltd is rated Sell by MarketsMOJO, with this rating last updated on 30 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News